Midatech Pharma Live Discussion

Live Discuss Polls Ratings
Page

pharmaspecialist 07 Sep 2015

Midatech equity cheaper in US If you are looking to buy Midatech for the long term you might like to consider buying a stake via its takeover target, Dara Biosciences in the US. As the press release states "The exchange ratio is subject to an implied acquisition price range of $1.08 to $1.32 per DARA share". At current prices the implied Dara price is nearer $1.08 than $1.32 but Dara is actually trading at $0.84 on NASDAQ so you effectively get a 20%+ discount on Midatech equity, assuming the deal goes through. You will end up with Midatech ADRs quoted on NASDAQ which may be less liquid that UK quoted Midatech shares, but I am sure there will be more US acquisitions to be merged with Dara so this should not be a long term problem. You even get an extra sweetener with Dara shares as there is a potential cash payment to ADR holders if sales of Dara's drugs are better than expected after the Midatech takeover. One thing I would say is don't rely on Mr. Woodford's judgement when investing in biotech. I'm sure he is a brilliant equity income investor but I find it bizarre that he is now investing in biotech - it's a bit like Anthony Bolton investing in China, only worse.

II Editor 17 Apr 2015

NEW ARTICLE: Maiden Midatech results fail to excite market "AIM-listed pharmaceutical company Midatech (MTPH) failed to excite the market with its maiden results since floating on the London Stock Exchange back in December. Although operationally successful, the update highlighted just how far away it is ..."[link]

totalnew 15 Apr 2015

Re: bought today I bought today in my SIPP ... I am thinking of investing heavily in these (20% of my pension). 60% in three funds and a further 20% in another share. Anyone think it is too risky?

nk1999 10 Feb 2015

Re: bought today Mentioned here:[link] also participated in a 267p-a-share IPO of Midatech Pharma, a company which uses tiny particles of pure gold to treat cancer and other medical conditions. Woodford stumped enough cash to give him 20% of the £74m AIM-listed firm's shares."nk

SpreadtheRisk 05 Jan 2015

Mail on Sunday Was tipped in the mail on Sunday and so there was bound to be a rise today.Looking to invest myself on the basis of good management and the holding by Woodford but will wiat for it to drop back slightly.

nondangerousdan 05 Jan 2015

Re: bought today going to for same reason and long term potential - but will wait now for fall back. Good Luck

zulu principle2 05 Jan 2015

bought today MIDATECH PHARMABought a few today at £3.01 based only that it is held by Woodford Fund Management who hold 20% of company

Page